education_image.jpg

Webinar 4 - Should we screen for Type 1 Diabetes in children?

Webinar 4 - Should we screen for Type 1 Diabetes in children? 

The ESPE Education and Training Committee are delighted to announce the fourth in their ESPE Connect webinar series.  These regular webinars offer high-quality scientific and educational content from our world-leading paediatric endocrinologists. ESPE Connect will present the latest developments covering all areas of paediatric endocrinology that you can view whilst it’s broadcast live or on-demand at your convenience.

Date: Thursday 17 March 2022

Time: 16:00-17:30 CET /15:00-16:30 GMT UK time

Programme:

  • Welcome - Dr Senthil Senniappan (Liverpool, UK) - ESPE Connect Webinar Convenor
  • Introduction to today's webinar - Professor Francesco Chiarelli (Chieti, Italy)
  • The stages of Type 1 diabetes development in children – Professor Moshe Phillip (Tel Aviv, Israel)
  • FOR routine diabetes screening in the general population - Professor Tadej Battelino (Ljubljana, Slovenia)
  • AGAINST routine diabetes screening in the general population - Professor Carla Greenbaum (Seattle, USA)
  • Panel Discussion
  • Webinar Close - Francesco Chiarelli (Chieti, Italy)

Each talk will be 20 minutes with Q&A for each speaker taking place during the panel discussion.

Our Speakers

Professor Moshe Phillip

Prof. Moshe Phillip graduated from Ben Gurion University, Beer Sheba, Israel, in 1983. Specialized in Pediatrics at Soroka Medical Center, Beer Sheba and in Pediatric Endocrinology at the University of Maryland School of Medicine, Baltimore.  He is the Director of the Institute for Endocrinology and Diabetes, the National Center for Childhood Diabetes at Schneider Children's Medical Center, Petah Tikva, Israel since 1997, and serves as Vice Dean for Research and Development as well as a Chair of the Irene and Nicholas Marsh Fund at the Sackler Faculty of Medicine, Tel Aviv University, Tel-Aviv.

Prof. Phillip is active in both clinical and basic research focusing on childhood diabetes and technologies for the treatment of diabetes, growth, nutrition, and obesity.

Prof. Phillip is a member of national and international organizations, such as the, the Israeli National Committee for Diabetes, ISPAD, ESPE, Endocrine Society, ADA and more.  He received the ESPE Research Award (2014), the ISPAD Achievement Award (2018) the ESPE Andrea Prader Award (2020).

He is co-founder and Co-Chairman of the International Conference for Advanced Technologies and Treatments for Diabetes (ATTD) and of the International Conference on Nutrition and Growth (N&G).

Prof. Phillip has published more than 400 manuscripts, chapters in books and is a co-editor of the ATTD and the Nutrition and Growth Yearbooks.

 

Professor Tadej Battelino

Tadej Battelino completed his medical degree at the University of Ljubljana in 1990. He completed a PhD focusing on glucose metabolism in neonatal endotoxic shock in 1996. He completed his clinical fellowship at Loyola University of Chicago, USA, and his postdoctoral fellowship at INSERM, Paris, France.

Professor Battelino is currently Consultant and Head of Department of Pediatric and Adolescent Endocrinology, UMC Ljubljana, Head, Chair of Pediatrics, and Professor of Paediatrics at Faculty of Medicine, University of Ljubljana. He is PI on several publicly funded research projects in the field of diabetes, endocrinology and metabolism, and was awarded the Slovene national award for research in 2014, Gold medal for research at the University of Ljubljana in 2017, and the ISPAD Achievement Award in 2020. Professor Battelino serves on the editorial boards for the journals Diabetes Care, Journal of Pediatric Endocrinology and Metabolism, and was Editor for the European Journal of Endocrinology from 2009 to 2015. He has authored or co-authored over 288 papers in international peer-reviewed journals and participated chapters to several international books. He has a cumulative h index of 55.

Professor Battelino is a member of numerous professional associations including the American Diabetes Association (ADA), European Society for Paediatric Endocrinology (ESPE) and the International Society for Pediatric and Adolescent Diabetes (ISPAD), for which he served as President for the 35th Annual Congress. He served on the European Association for the Study of Diabetes (EASD) council and is co-organizer of fourteen annual meetings of the Advanced Technologies and Treatment of Diabetes - ATTD. He is elected Honorary member of the Italian Society for Pediatric

Endocrinology and Diabetology (SIEDP) and the Hellenic Society of Pediatric and Adolescent Endocrinology (EEPEE). Professor Battelino is a member of the Slovenian Medical Academy, Slovenian Academy of Sciences and Arts (SAZU), and the European Academy of Sciences and Arts

Learning objectives: 

- rationale for the universal screening for T1D
- feasibility of the universal screening for T1D
- possible interventions for identified persons at high risk for developing T1D

 

Professor Carla Greenbaum

Dr. Greenbaum is Director of the Center for Interventional Immunology and the Diabetes Program at Benaroya Research Institute in Seattle, WA USA. She has served six years as Chair of Type 1 Diabetes TrialNet. Dr. Greenbaum’s research effort focuses on prediction and prevention of type 1 diabetes and discovery and validation of biomarkers. Her group has conducted a large number of both academic and industry trials of disease modifying therapy.

Learning objectives:

- What is the strength of the rationale for screening the general population?
- What are the potential harms of screening the general population?
- What challenges need to be addressed before general population screening is incorporated into clinical care

 

The March Webinar is kindly supported by ProventionBio.